Free tool
FAERS Monitor: Aridol Kit
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022368 or its brand name (Aridol Kit, Mannitol). Reports on generic versions are filed under their own applications.
Reports
4,906
Serious
4,670
95% of reports
Hospitalization
2,182
Death reported
1,418
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pain621
- renal failure592
- anxiety502
- injury495
- drug ineffective484
- stress473
- unevaluable event470
- fear430
- death415
- renal impairment394
- off label use393
- emotional distress386
- renal injury382
- nausea352
- vomiting335
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 116 |
| 2005 | 79 |
| 2006 | 89 |
| 2007 | 59 |
| 2008 | 87 |
| 2009 | 73 |
| 2010 | 105 |
| 2011 | 578 |
| 2012 | 255 |
| 2013 | 106 |
| 2014 | 144 |
| 2015 | 123 |
| 2016 | 223 |
| 2017 | 242 |
| 2018 | 215 |
| 2019 | 187 |
| 2020 | 220 |
| 2021 | 304 |
| 2022 | 376 |
| 2023 | 394 |
| 2024 | 395 |
| 2025 | 316 |
| 2026 | 219 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,253 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| fearSignal | 430 | 69.6 | 63.6 | 28,595 |
| renal injurySignal | 382 | 55.8 | 50.7 | 20,278 |
| injurySignal | 495 | 30.4 | 27.9 | 13,989 |
| stressSignal | 473 | 28.3 | 26.0 | 12,394 |
| unevaluable eventSignal | 470 | 26.8 | 24.6 | 11,614 |
| renal impairmentSignal | 394 | 20.2 | 18.4 | 7,165 |
| renal failureSignal | 592 | 19.2 | 17.8 | 10,210 |
| emotional distressSignal | 386 | 13.7 | 12.5 | 4,547 |
| anxietySignal | 502 | 7.6 | 7.0 | 2,892 |
| painSignal | 621 | 4.3 | 4.0 | 1,638 |
| vomitingSignal | 335 | 3.1 | 2.8 | 472 |
| deathSignal | 415 | 2.1 | 1.9 | 237 |
| off label use | 393 | 1.9 | 1.8 | 181 |
| nausea | 352 | 1.9 | 1.7 | 157 |
| drug ineffective | 484 | 1.6 | 1.4 | 108 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.